
Vanterra Ventures focuses its investments on the consumer health ecosystem, including products, services, and enabling technologies, with a particular emphasis on "ESY Investing" (better for the Environment, Society, and You) and digitally native brands. Their strategy involves making high-conviction, concentrated investments in seed and Series A rounds, actively supporting portfolio companies with resources and mentorship to foster long-term growth and profitability.
75% of their portfolio is in Healthcare. Their most common stage is series-a (100% of deals). Average disclosed round size is $10.1M (across 4 rounds with reported amounts).
Portfolio
4
Fund Size
$175M
Top Stage
Series A
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
4 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series A | $15M | Nov 2025 | |
| Series A | $5.5M | Nov 2024 | |
| AAllara | Series A | $10M | Oct 2023 |
| Series A | $10M | Aug 2023 |
Top Co-Investors
GV (Google Ventures)1 shared
Great Oaks1 shared
Humbition1 shared
Gaingels1 shared
One Medical1 shared
True Ventures1 shared
Twelve Below1 shared
Redesign Health1 shared
Blue Venture Fund1 shared
RiverPark Ventures1 shared
Palm Tree Crew1 shared
Simple Food Ventures1 shared
Last updated: 10 April 2026